top of page

Cities@Heart welcomes Rebecca Fowler as new industry lead

Nov 12
2 min read

Rebecca Fowler, Head of ASCVD at Novartis, has been appointed Industry Lead of Cities@Heart. She takes over from Franck Perraudin, who has held the role since the project began in January 2026.



Cities@Heart is a five-year public-private partnership working to reduce the burden of cardiovascular disease (CVD) and health inequalities in European cities. It has a new Industry Lead. Rebecca Fowler, Head of ASCVD (atherosclerotic cardiovascular disease) at Novartis, takes over from Franck Perraudin, who is stepping down from the role.




A new lead for the public-private partnership

Cities@Heart is funded by the Innovative Health Initiative Joint Undertaking (IHI JU). It brings together municipalities, universities, health services, patient and professional organisations, and industry partners. The work spans seven pilot cities: Belfast, Birmingham, Cork, İzmir, Łódź, Udine, and Utrecht.


The Industry Lead works alongside Project Director Dipak Kotecha (University of Birmingham and UMC Utrecht) and Project Coordinator Sanne Peters (UMC Utrecht). Together, they lead a consortium whose industry partners are Novartis, Novo Nordisk, Servier, Menarini, Daiichi Sankyo, and Huawei.


Rebecca brings more than 25 years of experience in the pharmaceutical industry, with leadership roles in countries and regions around the world. Most recently, she was Managing Director of Takeda Austria.


She says she is looking forward to getting to know the Cities@Heart team, learning from the work already under way, and building on the strong partnership and foundations established with Franck.


"I am delighted to join the Cities@Heart project and look forward to working closely with the consortium to advance our shared ambition of improving cardiovascular health in cities in Europe. The collaborative nature of this initiative, bringing together diverse expertise across sectors, is a powerful opportunity to help drive meaningful impact for people living with, or at risk of, ASCVD,"

she said as she took up her new position.


Thanking Franck Perraudin

Franck has served as Industry Lead since Cities@Heart began. He has been closely involved in its first year, during which the consortium set up its governance structures and began mapping CVD burden and inequalities in the pilot cities. Franck has been highly committed to convincing the cardiovascular community of the impactful initiative that Cities@Heart is.


The consortium thanks Franck for his leadership since the project began, and for his commitment to the public-private partnership at the heart of Cities@Heart.




Comments


Funding

Cities@Heart is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101219389. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Europa Bío, MedTech Europe and Vaccines Europe. ​

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.

MedTech Europe
Vaccines Europe
EuropaBio
Innovative Health Initiative
Co-funded by the European Union
COCIR
EFPIA
bottom of page